Vaxcell-Bio Therapeutics (Korea) Buy Hold or Sell Recommendation
| 323990 Stock | KRW 9,380 60.00 0.64% |
Assuming the 90 days trading horizon and your conservative attitude towards risk, our recommendation regarding Vaxcell Bio Therapeutics Co is 'Strong Sell'. Macroaxis provides Vaxcell-Bio Therapeutics buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding 323990 positions.
Check out Vaxcell-Bio Therapeutics Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. In addition, we conduct extensive research on individual companies such as Vaxcell-Bio and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Vaxcell Bio Therapeutics Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
Vaxcell-Bio |
Execute Vaxcell-Bio Therapeutics Buy or Sell Advice
The Vaxcell-Bio recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Vaxcell Bio Therapeutics Co. Macroaxis does not own or have any residual interests in Vaxcell Bio Therapeutics Co or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Vaxcell-Bio Therapeutics' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Very steady | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Below Average | Details | |
Economic Sensitivity | Almost neglects market trends | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Vaxcell-Bio Therapeutics Trading Alerts and Improvement Suggestions
| Vaxcell-Bio Therapeutics generated a negative expected return over the last 90 days | |
| Net Loss for the year was (4.76 B) with loss before overhead, payroll, taxes, and interest of (5.39 M). | |
| Vaxcell Bio Therapeutics Co has accumulated about 27.31 B in cash with (4.66 B) of positive cash flow from operations. | |
| Roughly 14.0% of the company shares are owned by insiders or employees |
Vaxcell-Bio Therapeutics Returns Distribution Density
The distribution of Vaxcell-Bio Therapeutics' historical returns is an attempt to chart the uncertainty of Vaxcell-Bio Therapeutics' future price movements. The chart of the probability distribution of Vaxcell-Bio Therapeutics daily returns describes the distribution of returns around its average expected value. We use Vaxcell Bio Therapeutics Co price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Vaxcell-Bio Therapeutics returns is essential to provide solid investment advice for Vaxcell-Bio Therapeutics.
| Mean Return | -0.5 | Value At Risk | -5.53 | Potential Upside | 3.99 | Standard Deviation | 2.60 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Vaxcell-Bio Therapeutics historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Vaxcell-Bio Therapeutics Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Vaxcell-Bio Therapeutics or Vaxcell-Bio sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Vaxcell-Bio Therapeutics' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Vaxcell-Bio stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.51 | |
β | Beta against Dow Jones | -0.3 | |
σ | Overall volatility | 2.60 | |
Ir | Information ratio | -0.19 |
Vaxcell-Bio Therapeutics Volatility Alert
Vaxcell Bio Therapeutics Co exhibits very low volatility with skewness of -0.56 and kurtosis of 2.04. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Vaxcell-Bio Therapeutics' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Vaxcell-Bio Therapeutics' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Vaxcell-Bio Therapeutics Fundamentals Vs Peers
Comparing Vaxcell-Bio Therapeutics' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Vaxcell-Bio Therapeutics' direct or indirect competition across all of the common fundamentals between Vaxcell-Bio Therapeutics and the related equities. This way, we can detect undervalued stocks with similar characteristics as Vaxcell-Bio Therapeutics or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Vaxcell-Bio Therapeutics' fundamental indicators could also be used in its relative valuation, which is a method of valuing Vaxcell-Bio Therapeutics by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Vaxcell-Bio Therapeutics to competition |
| Fundamentals | Vaxcell-Bio Therapeutics | Peer Average |
| Return On Equity | -21.18 | -0.31 |
| Current Valuation | 1.06 T | 16.62 B |
| Shares Owned By Insiders | 13.55 % | 10.09 % |
| Shares Owned By Institutions | 3.92 % | 39.21 % |
| Gross Profit | (5.39 M) | 27.38 B |
| EBITDA | (4.06 B) | 3.9 B |
| Net Income | (4.76 B) | 570.98 M |
| Cash And Equivalents | 27.31 B | 2.7 B |
| Total Debt | 37.39 M | 5.32 B |
| Cash Flow From Operations | (4.66 B) | 971.22 M |
| Market Capitalization | 554.12 B | 19.03 B |
| Total Asset | 31.28 B | 29.47 B |
| Net Asset | 31.28 B |
Vaxcell-Bio Therapeutics Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Vaxcell-Bio . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Vaxcell-Bio Therapeutics Buy or Sell Advice
When is the right time to buy or sell Vaxcell Bio Therapeutics Co? Buying financial instruments such as Vaxcell-Bio Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Vaxcell-Bio Therapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Military Industrial Thematic Idea Now
Military Industrial
A collection of large United States defense contractors including companies involved in production or distribution of aircraft, ships, vehicles, weaponry, and electronic systems in cooperation with the government. The Military Industrial theme has 35 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Military Industrial Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Vaxcell-Bio Stock
Vaxcell-Bio Therapeutics financial ratios help investors to determine whether Vaxcell-Bio Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Vaxcell-Bio with respect to the benefits of owning Vaxcell-Bio Therapeutics security.